Cannabis banking has had two facts driving it since 2014. Fact one: federal law treats marijuana proceeds as proceeds of a Schedule I controlled substance, which makes anyone touching them potentially exposed under the BSA, money-laundering statutes, and the entire AML edifice. Fact two: FinCEN issued FIN-2014-G001 that February to say financial institutions could serve marijuana-related businesses with appropriate due diligence and SAR reporting.
Cannabis operators have been living with the gap between fact one and fact two for twelve years. On April 22, 2026, fact one moved. State-medical-licensed marijuana is now Schedule III. Schedule III is not Schedule I. The proceeds-of-Schedule-I premise that scared banks off every cannabis MRB account no longer applies to covered activity.
This post explains what cannabis banking under Schedule III looks like in practice, what the eight files every bank wants in your folder, and why your existing banking relationship is suddenly worth more — but only if you build the right file before your bank’s compliance team rebuilds it for you.
What Schedule III actually changed for cannabis banking
Three things changed for cannabis banking Schedule III strategy on April 22, 2026:
- The federal-illegality predicate is gone for covered activity. Banks underwriting state medical marijuana licensee accounts can argue the proceeds are not Schedule I marijuana trafficking. That is a different conversation than the one banks were having on April 21.
- Your bank’s risk-rating models need to be updated. Most cannabis MRB programs assigned high-risk ratings tied to federal illegality. Schedule III recognition reduces — but does not eliminate — that risk. Compliance teams are recalibrating right now.
- The 2014 FinCEN guidance still applies. This is the part nobody on Twitter is reading. FinCEN’s FIN-2014-G001 was not vacated. Banks still must perform due diligence, file SARs, monitor expected activity, and verify state license status. What changed is the content of the diligence file, not the existence of the obligation.
What did NOT change for cannabis banking Schedule III analysis
Five things explicitly did not change for cannabis banking under Schedule III. We are listing them because every cannabis CFO is currently being told by some yahoo on LinkedIn that they should expect their bank to drop SAR filings tomorrow.
- BSA / AML obligations remain in force. 31 C.F.R. § 1020.320 SAR rules still apply.
- The 2014 FinCEN guidance still applies. Both as a floor (banks still must do this) and as a ceiling (banks have this much room to serve MRBs).
- 18 U.S.C. §§ 1956 and 1960 — money-laundering and unlicensed money transmission — still apply to any marijuana proceeds. Schedule III recognition narrows but does not eliminate the analysis.
- Federal banking regulators (OCC, FDIC, Federal Reserve, NCUA) have not issued new guidance. They will. They have not yet.
- Reputational risk is still a factor for every bank. Several banks served MRB accounts pre-April 2026 and several didn’t, on policy grounds. Schedule III does not force a bank to change its policy.
If you are reading those five and thinking “so my bank isn’t going to do anything different,” the right answer is: your bank is going to do something different. They are going to update the file. The question is whether you give them what they need or whether they have to chase it down. The latter risks account closure as a precaution.
The 8 critical files cannabis banks want under Schedule III
This is the state medical endorsement file every cannabis MRB customer should hand-deliver to their bank’s BSA officer this quarter.
File 1 — State medical marijuana license + endorsement documentation
The federal predicate for everything else. Pull your current license, every renewal in the past 24 months, every endorsement (medical, OTC therapeutic, patient-facing, retail, manufacturing, cultivation, distribution), and any pending license actions. Confirm explicitly that your license qualifies as a “state medical marijuana license” under the DOJ Final Order.
If your state has not yet added a medical endorsement to your existing adult-use license, this is now urgent. See Adult Self-Certification for Cannabis for the operator playbook on getting your state to add the endorsement.
File 2 — Regulator-verifiable license status
Banks will not take your word for license status. Provide a regulator URL or QR code that lets the bank’s compliance team verify your license in real time. Most state cannabis commissions have public license-verification portals. Identify yours, link it in your bank file, and confirm with the regulator that they update real-time.
File 3 — Beneficial ownership and control persons
FinCEN’s CDD rule (the “beneficial ownership rule”) applies to MRBs the same as anyone else. Capture all 25%+ owners, all senior officers, and the person responsible for compliance. Make sure your bank’s KYC/CDD records match your state license records exactly. Mismatches between state license ownership and bank KYC are the most common cause of cannabis account freezes.
File 4 — Expected activity profile
FinCEN guidance requires banks to understand expected activity and monitor for variance. Provide:
- Monthly expected revenue range
- Customer-count expectations (retail) or wholesale-account counts (B2B)
- Cash deposit ranges
- Wire activity ranges
- Inter-business transfers (within your corporate structure)
- Vendor payment patterns
File 5 — Transaction-level medical-purpose records
This is the new file. Under the OTC Therapeutic Cannabis Endorsement model, every retail transaction generates a medical-purpose record (license number, customer self-certification, product SKU, intended-use category, employee/consultant ID). For B2B, every transaction is between two state-medical-licensed entities. Provide the bank with:
- Sample transaction records (redacted for customer privacy)
- The schema and data fields your POS captures
- Your aggregated medical-purpose volume by month
This is what makes the “covered activity” argument concrete. Without it, the argument is hand-wave.
File 6 — Anti-diversion and youth-access controls
FinCEN’s red-flag list still includes potential diversion to minors, interstate transport, sales of unlicensed product, and structuring. Show your controls:
- ID verification protocol
- Purchase-limit enforcement
- POS holds for high-volume / high-frequency customers
- Recall and adverse-event procedures
- Audit logs
File 7 — Tax compliance certificate
Federal and state tax filings current, no liens, no audit findings. If you are taking a 280E retrospective relief position, disclose it — your bank’s compliance team needs to know your tax position. See 280E Retrospective Relief for that playbook.
File 8 — The federal readiness package
A consolidated cover memo showing all of the above plus:
- Current state license + endorsement status
- DEA registration status (if applicable — see Federal Cannabis License)
- Inspection history (clean / disciplinary)
- Material incidents (recalls, security breaches, compliance violations)
- Regulator-verifiable compliance certificate
- Designated bank-relationship contact
This is the file we build for the Banking & Payments Compliance Packet product. CTA at the bottom.
For banks: updating your cannabis banking Schedule III program
The cannabis banking Schedule III playbook for banks looks different than for operators. If you are reading this from inside a bank, your update list:
The immediate cannabis banking Schedule III implementation steps:
- Update your risk-rating model. Distinguish state-medical-licensed cannabis MRBs from other cannabis MRBs. The former should rate lower than the latter post-April 2026.
- Update your SAR narratives. SAR filings on covered activity should reflect Schedule III status. The narrative changes; the obligation to file does not disappear.
- Update your CDD due-diligence checklist. Add the eight files above.
- Update your account-opening criteria. Many banks had blanket cannabis prohibitions. The Schedule III moment is the right time to reopen the policy review.
- Coordinate with your federal regulator. OCC / FDIC / Fed examiner conversations should happen now, before exam cycle. Schedule III does not change examination expectations but the file you produce in exam will.
We work with banks on all five. The Banking & Payments Compliance Packet is built for both directions.
Hemp banking vs. cannabis banking under Schedule III
Quick clarification because every cannabis CFO is asking and the answer is different. Hemp is defined by the 2018 Farm Bill and is not in Schedule III; it is not a controlled substance at all (when properly within the THC threshold). Hemp banking is a separate, different conversation governed by the FinCEN guidance updated for hemp in 2020 and the Farm Bill threshold. We covered the post-FinCEN-update hemp banking landscape in Hemp banking after FinCEN guidance.
If you operate both hemp and cannabis lines, your bank file should distinguish them clearly and your accounting should not commingle revenue. Do not let your bank discover the commingling on a SAR review.
Cannabis banking Schedule III FAQ
Will my bank close my cannabis account because of Schedule III?
Most banks will not. The Schedule III moment is materially friendlier than April 21, not less friendly. Account closures historically have been driven by federal-illegality risk, which is now reduced for covered activity. The risk is closure due to non-cooperation with the bank’s updated due diligence. Cooperate, deliver the file, and the relationship strengthens.
Can I open a new cannabis account at a major bank now?
Maybe. Some major banks have policy prohibitions on cannabis MRBs that are policy-based (not federal-illegality-based) and Schedule III does not change those. Other banks reopened the analysis on April 23 and are quietly accepting applications. Treat it case by case.
Do I still need to file Currency Transaction Reports?
Yes. CTR thresholds (cash transactions over $10,000) apply to MRBs the same as anyone else. Schedule III did not change the BSA.
Will my bank stop filing SARs on my account?
No. The 2014 FinCEN guidance still requires SARs for cannabis MRBs. The narrative will reflect Schedule III status going forward, but SARs will continue.
What if my state hasn’t passed an OTC Therapeutic Endorsement yet?
Your bank file is weaker. Adult-use-only licenses don’t qualify as state medical marijuana licenses under the Final Order. That doesn’t mean your bank will close your account; it means your covered-activity argument is narrower. The longer-term fix is state legislation. See The OTC Therapeutic Cannabis Endorsement Model Act.
Build your cannabis banking Schedule III file
The Banking & Payments Compliance Packet is engineered for this exact moment. We build the full eight-file federal readiness package, draft your bank-relationship cover memo, prepare your regulator-verification documentation, and (if your bank is reluctant) help you find a bank that is actively expanding its MRB program post-Schedule III.
Get the Banking & Payments Compliance Packet.
For the full hub, see Schedule III Cannabis: The Operator, Lawyer & Investor Hub.
- DOJ Final Order Explained (Cluster 1)
- Credit Card Processing for Cannabis Dispensaries (Cluster 4)
- Federal Cannabis License: 10 Critical DEA Steps (Cluster 7)
- Cannabis Consulting at collateralbase.com — operator buildout for the bank-readiness file
- FinCEN BSA Expectations Regarding Marijuana-Related Businesses (FIN-2014-G001)
- DOJ Final Order
- Article + FAQPage
External ≥2
Cross-site ≥1
Schedule III Cannabis · Cannabis Banking · Federal Cannabis Legalization
cannabis banking · Schedule III · FinCEN · BSA SAR · cannabis MRB · marijuana related business · 2014 FinCEN guidance · state medical marijuana license · cannabis compliance
Want the full Schedule III playbook?
This post is one cluster of The Schedule III Cannabis Hub, the operator, lawyer, and investor briefing on DOJ’s April 2026 Final Order.